LESLIE WARD: Open Payments
NPI 1861695132 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,919 in 37 payments from 12 companies in 2025. Trend: 2023 $2,052 · 2024 $346 · 2025 $1,919
Consulting: $1,090Food & beverage: $829
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 10 | $1,353 |
| ViiV Healthcare Company | 9 | $201 |
| Supernus Pharmaceuticals, Inc. | 5 | $88 |
| ABBVIE INC. | 3 | $76 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Boston Scientific Corporation | 1 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| EMD Serono, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $18 |
Products named: Biktarvy, CABENUVA, Qelbree, DOVATO, MAVYRET, JOURNAVX, CAPLYTA, UBRELVY.
Industry payments across AR — which companies pay providers there.
